NeuroOne Medical TechnologiesNMTC

13F holders, Q3 2024 (September 30)
1holders
0new positions
0sold out
$0.99avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding NeuroOne Medical Technologies (NMTC) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was AWM Investment Company, Inc. ($1.2M).

Company
NeuroOne Medical Technologies
CUSIP
64130M100
Latest filing quarter
Q2 2025

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q2 2024 → Q3 2024: 250,000 shares bought, net +250,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

AWM Investment Company, Inc. 0.14% Add +26.3% 1,200,000 $1.2M

"% of holder's portfolio" is NMTC's weight in each manager's 13F, not the share of NeuroOne Medical Technologies the manager owns.